In Bangladesh, workers wade into muddy, parasite-infested waters near the Sundarban mangrove forests to catch baby shrimp that will later be processed for export. Elsewhere in rural South Asia, they toil in locked buildings, weaving luxury carpets on filthy, ramshackle looms.These workers, many of them children, often work 14 or more hours a day. They are bonded laborers—essentially, slaves.According to Siddharth Kara, six out of every 10 slaves in the world—between 18.5 and 22.5 million people—are bonded laborers. Kara, a fellow on forced labor at the FXB Center for Health and Human Rights at Harvard School of Public Health (HSPH) and a fellow on human trafficking at the Carr Center for Human Rights Policy at Harvard Kennedy School, says these slaves work in a wide range of industries: rice, tea, frozen fish and shrimp, carpets, cigarettes, fireworks, construction, brickmaking, minerals and stones, gems, and apparel.An expert on contemporary slavery, Kara read from his new book,???Bonded Labor: Tackling the System of Slavery in South Asia, and answered questions at a reception celebrating the book’s publication, at HSPH on November 7, 2012. The new book is the second of three Kara is writing about modern slavery. The first, Sex Trafficking: Inside the Business of Modern Slavery, was named co-winner of the prestigious 2010 Frederick Douglass Award at Yale University for the best nonfiction book on slavery.
In the mid-1980s, the U.S. Navy wanted deep-sea explorer Robert Ballard to launch a secret expedition to investigate two sunken subs, one of which still held nuclear weapons. Ballard agreed, telling them, “Have I got the perfect cover story.”That “story” turned out to be the search for the Titanic, which Ballard found in 1985 with the help of deep-diving drones the Navy agreed to finance for the sub expedition.The Titanic was the perfect cover story, Ballard said, because it was located between the wrecks of the U.S.S. Scorpion and the U.S.S. Thresher. The Navy let him search for the famed ocean liner only after the submarine mission was complete, which left him little time. Still, lessons from the sub search served him well. Instead of focusing on the Titanic itself, he looked for signs of the debris trail and, once found, followed it to the wreck.The drones Ballard used heralded their widespread adoption — in water and air and on land — and also helped him in later notable discoveries, including the German battleship Bismark (1989), the U.S. aircraft carrier Yorktown (1998), and ancient marine archaeological finds in the Mediterranean and the Black Sea.The continued development of undersea drones is the future of deep-sea exploration, Ballard said during a Harvard talk on Wednesday.He shared an anecdote of a time when researchers aboard his ship, the E/V Nautilus — named after Jules Verne’s famed “Twenty Thousand Leagues Under the Sea” submarine — contacted Harvard microbiologist Peter Girguis on a plane at 35,000 feet. Within minutes, Girguis, a professor of organismic and evolutionary biology and an expert in the microbiology of the sea floor, was directing researchers himself, taking virtual charge of the operation.That episode, Ballard said, contained a glimpse of a future in which dark, dangerous work once done by humans in deep-sea submersibles is instead carried out by robotic subs in constant communication with research vessels.Scientists and technicians will increasingly use satellite communications to connect with colleagues around the world, transforming lonely descents to the deep into networked, high-speed, and — at least for those participating from home — even comfortable endeavors.Ballard, director of the University of Rhode Island’s Center for Ocean Exploration and president of the nonprofit Ocean Exploration Trust, drew a standing room-only crowd of more than 300 to the Geological Lecture Hall. In his talk, sponsored by the Harvard Museum of Natural History, one of the Harvard Museums of Science and Culture, he returned to the roots of his love affair with the sea, notably an early reading of “Twenty Thousand Leagues” and a childhood move to San Diego.Ballard also described his early submarine experience as a Navy officer, as well as decades exploring the sea floor and undersea hydrothermal vents, much of it via the submersible Alvin.Such adventures take a back seat with scientific funders, Ballard said, drawing only 1/1,000 the support that space exploration does. That means, he said, that the surface of Mars is more familiar to scientists than that of our own planet. The mid-ocean ridges alone, mountain ranges that run around the planet “like the seams of a baseball,” cover some 23 percent of the Earth’s surface and are rich in ores like copper, lead, zinc, and gold, yet have drawn relatively little attention.In fact, Ballard said, most of the planet is entirely unlike the world humans know. It is covered by ocean with an average depth of 13,000 feet, far below the depth that light can penetrate.“Most of the Earth is in eternal darkness and will never feel the warmth of the sun,” Ballard said.What the deep sea does absorb, however, is the warmth of the Earth, and Ballard described his role in discovering the abundant life around hydrothermal vents, whose rich chemical soup sustains tubeworms, giant clams, and other strange creatures.Ballard said it was his long experience traveling to the ocean floor and back — days when his commute was 2½ hours each way for just three hours on the bottom — that made him look toward undersea drone development.“[We were] trying to explore 72 percent of the planet at 1 knot,” Ballard said.Today, his emphasis is on engaging a new generation of explorers and exposing kids to the wonders of science. The United States, he said, spends more than all but one other industrialized country on education, yet ranks 27th in education in STEM subjects — science, technology, engineering and math.When he returned from the Titanic expedition, Ballard said, his desk was buried under letters from kids asking how they could grow up to do what he does. Since then, he said, he responds to such letters by telling the writers to apply themselves, always signing off “study hard.”Currently Ballard is engaged in a re-creation of the 19th century Challenger exploration, during which the British ship traveled around the world, conducting dredges and trawls and discovering some 4,000 new species. So far, Ballard said, his Nautilus research ship has covered 10,000 miles, with six more months at sea planned for next year. Even at sea, despite the scientific demands of the moment, he makes time to answer questions from schoolchildren.“I’m really excited about getting the next generation involved,” Ballard said. “Middle school is the battlefield.”
Patients with severe TB disease when they started treatment had worse outcomes than patients with less severe disease. Sixty-eight percent of people with severe disease had early favorable responses to the new regimen, compared to 89 percent without severe disease. Among patients with HIV coinfection, early outcomes on the new regimens were favorable in 73 percent, compared to 84 percent in those without HIV.The results are based on an analysis of early treatment results from more than 1,000 MDR-TB patients who were enrolled in the study between April 2015 and March 2018. The study examines outcomes after six months in a treatment that lasts 15 months or longer. Long-term effectiveness will be measured at the end of treatment and during follow-up.For this study, the researchers counted how many of those patients, within the first six months of treatment with regimens containing bedaquiline, delamanid, or both, experienced culture conversion, a state in which the bacteria that cause TB can no longer be found on a sample. Previous studies have shown this to be a strong predictor of successful treatment outcomes.Confirmation with end-of-treatment outcomes will be important and more work needs to be done to ensure successful treatment in these populations, the researchers said.“The early results from these studies offer convincing evidence that these new regimens offer a very promising alternative to the historical regimens that achieve approximately 60 percent success at end of treatment, and to other new treatments that are becoming available,” said Mitnick, who is a senior researcher at Partners In Health and co-principal investigator of the clinical trials being conducted by endTB.“We’re eager to follow these patients as they progress through treatment in order to verify the effectiveness of these new regimens,” she added.Complex challengesObservational research makes so many important contributions to improving treatment outcomes for complex illnesses in complicated populations that it is critical to continue research efforts past the stage of clinical trials in illnesses like tuberculosis, the researchers said.While tuberculosis has nearly disappeared in wealthier populations, it remains a critical threat in communities with fewer resources. A big part of the challenge of treating MDR-TB is finding regimens that will work in low-resource settings with complex populations that often include great diversity and many people who might be undernourished or sick with other illnesses.The partnership is also studying the safety of the new regimens. Preliminary results suggest that side effects from the new regimen may be much less severe than those seen with the historical treatment, which has been known to cause deafness and psychosis.“TB is well-controlled where control is easy,” Mitnick said. “We need to find better ways to treat it where it’s difficult.”The global reach of endTB has now provided clinicians with invaluable hands-on experience with bedaquiline and delamanid and helped change country guidelines, getting the new drugs registered for use in more than half of the17 endTB countries, the researchers said. The endTB observational study has contrinuted to changing global guidelines, including new recommendations for concomitant use of bedaquiline and delamanid and extended use of each drug.Moving forwardThe endTB partnership is using the same model for promoting innovation to prepare for what researchers hope will be the next change on the horizon in care for MDR-TB: all-oral, shortened regimens, which are being studied in the current phase of endTB’s clinical trial. While the implementation program continues to roll out and reaches new patients, the endTB trial has enrolled 465 patients with MDR-TB in new all-oral regimens that could transform care for MDR-TB.The all-oral regimens used in the endTB observational study and the all-oral, shortened regimens studied in the trials would be particularly helpful during international health crises like the coronavirus pandemic, the researchers noted. These all-oral regimens are much easier to deliver in routine times and especially so in times of extreme crisis that burden health systems.“If the ongoing trials demonstrate reduced toxicity of the all-oral, shortened regimens, this is another huge benefit for their delivery in good times and bad,” Mitnick said.The project also transformed the landscape for TB trials by running in six countries (Georgia, Kazakhstan, Lesotho, Pakistan, Peru, South Africa) on four continents. This is the first time a clinical trial has taken place in some of these sites, the researchers said.“In global health we see many vicious cycles, where poverty and lack of access to care combine to make diseases worse,” Franke said. “On the other hand, bringing care delivery, training and research together the way we are in the endTB project can be a kind of virtuous cycle, where each turn of the wheel brings better care, improved health and greater well-being.”The endTB project is funded by Unitaid. International epidemic expertise to help Massachusetts respond to COVID-19 New blood monitoring could be used to help people infected with tuberculosis New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.The results, based on observational data from a diverse cohort of patients in 17 countries, underscore the need for expanded access to the recently developed TB medicines bedaquiline and delamanid. By contrast, the historical standard of care, still in use in much of the world, has approximately 60 percent treatment efficacy globally.The study was published July 24 in the American Journal of Respiratory and Critical Care Medicine.“This is important evidence that these new regimens will work well for the true population suffering from this disease,” said lead study author Molly Franke, associate professor of global health and social medicine in the Blavatnik Institute at Harvard Medical School.Global collaborationThe research was conducted as part of endTB, an international partnership with leaders from HMS, Partners In Health, Médecins Sans Frontières, Interactive Research & Development, the Institute of Tropical Medicine in Antwerp, and Epicentre.“Our findings underscore the need for urgent expanded access to these drugs,” said Carole Mitnick, associate professor of global health and social medicine in the Blavatnik Institute at HMS and a co-author of the study. While recent announcements of a price reduction for bedaquiline and an expected reduction for delamanid are welcome, the researchers said, more must be done to improve treatment guidelines worldwide and to scale up treatment with these new regimens.The need for better treatments for MDR-TB is dire. The WHO estimates that there are nearly 500,000 new cases of MDR-TB per year and that nearly 200,000 people die of the disease each year . In 2018, only one out of three patients were given an effective treatment, and only half of these were cured.New hopeIn the early 2010s, regulatory agencies approved the first new TB drugs in 50 years, bedaquiline and delamanid, offering hope for more effective and less toxic MDR-TB treatment. With the historical standard of care and some newer regimens, certain subgroups of patients, including those with HIV or hepatitis C or diabetes experience worse treatment outcomes than patients without these conditions. In addition, these conditions preclude patients from participating in clinical trials for these drugs.It’s important to examine whether these subgroups experience any benefit from the new regimens that might be observed in healthier study participants, the researchers said. They noted that only a large cohort study has the statistical power to explore these differences.The endTB study showed that for the new regimens, early treatment response was similar for patients without serious comorbidities or other complicating factors and for those with diabetes, hepatitis C and severe drug resistance. Related Community contact tracing A timely triage test for TB
Nationally, the gleaning program gathered more than 1,000 tons of food. That became 1.3million meals for hungry people. It won’t feed everybody. But it’s a start. Today, hunger is closer to home. Every day, chronic hunger and malnutrition stalk 30 million Americans, including far toomany Georgians. The United Nations Food and Agriculture Organization (FAO) puts theglobal figure at 800 million people. That’s one person in seven. “About 70 percent of Georgians don’t believe there has been progress on the hungerchallenge,” Andress said. “Two in five think hunger problems are about the same as in 1991.One in four believes they’ve gotten more serious.” The U.S. Department of Agriculture is offering $1 million in grants to help communities getbetter at doing just that. On the other hand, one Georgian in five feels hunger isn’t a serious problem at all. It’s part of a growing focus on hunger. University of Georgia food and nutrition experts are helping study hunger in Georgia. Theyjust finished a telephone survey of 400 adults to learn how Georgians view hunger. DougBachtel, a rural sociologist, leads the effort. In Georgia, teachers and food providers are helping each other battle the problem locally. Aprogram called Fighting Hunger in Georgia helps link food providers with other resources andwith each other. Projects include setting up partnerships between farmers and low-income communities,training community gardeners and using donated lands to expand a food bank’s farmingcapacity. On World Food Day Oct. 16, the world joined in a live broadcast to highlight the role ofpeople to assure food security for poor communities. On Nov. 13-17 in Rome, political leaderswill come together for the FAO-sponsored World Food Summit. When you didn’t clean your plate as a child, what did your mother say? “Think of the starvingchildren in Africa or India.” Yet farmers produce bumper crops. Stores stock shelves overflowing with food. Andrestaurants throw away food every day. The dilemma is how to get food to the hungry. Even though people acknowledge the problem, few know it personally. “Only one in four Georgians knows someone who has skipped a meal due to a lack of money,”Andress said. “Younger women and working women are more likely to know someone whohas forgone a meal. And one in three Georgians making $40,000-$60,000 knows someonewho has gone hungry.” Only 10 percent of Georgians are very familiar with their communities’ programs to aid thehungry. During the summer Olympic Games, the world heard about the USDA AmeriCorps gleaningprogram. During the two weeks of the Games, volunteers gleaned 174 tons of excess foods. Elizabeth Andress, a food and nutrition expert with the UGA Extension Service, called theearly findings encouraging. The Fighting Hunger in Georgia program will now ask focus groups of providers andrecipients to look at services for the hungry. They’ll ask about improvements being made andbarriers to success. Women seem more sympathetic than men, especially women between 18 and 44. BlackGeorgians are more likely than whites to report hunger as a serious problem. “Although hunger wasn’t the first issue to come to mind for Georgians, almost half of adultsthink it’s a serious problem here,” Andress said. “In fact, almost one in three says hunger issomewhat of a serious problem in their communities.”
Photo by David McClisterAs Patterson Hood sings the chorus in “The Righteous Path,” a hard-hitting standout from the Drive-By Truckers’ new sprawling 35-track live album, his gravelly voice sounds a little more weathered than usual. Not that the wear and tear hasn’t been well earned. Hood is now 51 and he’s been fronting the Truckers alongside his main songwriting foil Mike Cooley for just shy of 20 years. In the two decades since the band emerged from Athens, Ga., it has played approximately 2,000 shows, released 10 studio albums, and had 14 different members. Impossible to calculate but no less relevant to the experience are the number of relentless road miles between gigs, Jack Daniels bottles killed onstage, or the eardrums permanently damaged at the band’s rowdy, deafeningly loud rock shows.It’s Great to Be Alive!, which will be released on October 30, comes across as a grand retrospective that celebrates the Truckers’ scrappy longevity, despite some turmoil. Culled from a three-night stand at the legendary Fillmore Auditorium in San Francisco, the effort finds Hood and Cooley trading tunes that touch every part of the band’s impressively prolific discography.Through the years various line-ups have adjusted the band’s Southern rock sound—a mix of big distorted anthems, twangy thought-provoking ballads and even some of the dusty soul from Hood’s upbringing in Alabama as the son of the bassist of the famed Muscle Shoals Rhythm Section. The common thread, however, has always been Hood and Cooley’s vivid lyrics, which illustrate with brutal honesty many hard-to-swallow aspects of life in the South.That’s on full display in the new live set, as Hood revisits “The Living Bubba,” a tragic story song about a bar musician with AIDS who finds the will to live through his nightly shows that first surfaced on the Truckers’ primitive 1998 debut Gangstabilly. Cooley shines on the band’s more recent material, particularly the politically charged “English Oceans,” where he tells the crowd a story about growing up in Alabama and remembering being embarrassed when a visit from then-President Jimmy Carter to his hometown was interrupted by the KKK.Make no mistake: the Truckers’ lead songwriters are both proud of where they come from. You can hear it when Hood gets personal looking back at his 1999 song “Box of Spiders,” written for his grandparents. But they’ve also never been willing to sugarcoat the region’s shortcomings. The Truckers’ critical breakout came after the 2001 release of Southern Rock Opera, a two-disc concept album about growing up in the South, creatively filtered through reverence for Lynyrd Skynyrd. Hood referenced the album in July when he wrote a poignant op-ed in the New York Times Magazine about the Confederate Flag controversy that followed the tragic mass shooting at the Emanuel African Methodist Episcopal Church in Charleston, S.C.“The album wrestled with how to be proud of where we came from while acknowledging and condemning the worst parts of our region’s history,” he wrote, while also elaborating on his craft. “As a songwriter, I’ve spent the better part of my career trying to capture both the Southern storytelling tradition and the details the tall tales left out, putting this dialectical narrative into the context of rock songs.”That sums up what’s destined to be the band’s cemented legacy, something worth noting at a time when the group finally seems to have a comfortable roster. The band has admitted to internal discord as notable members have come and gone through the years, including Americana tunesmith Jason Isbell, who wrote some of the band’s most popular songs during his six-year tenure.These days, though, the Truckers play as a lean five-piece outfit that is arguably its tightest incarnation. Hood and Cooley handle the guitars with steadfast drummer Brad Morgan behind the kit. Spunky bassist Matt Patton holds down the low end, and the unsung hero is keyboardist Jay Gonzalez, who shines on It’s Great to Be Alive! by easing the intensity of the distortion with gospel-hued organ accents, funky vamps, and airy piano fills.The new album closes with “Grand Canyon.” The song is a moving elegy for Craig Lieske, a band crew member who passed away suddenly of a heart attack in 2013. It’s meditative and melodic, persisting for more than 13 minutes before patiently reaching a crashing peak that tapers off into piercing single note of feedback. When Hood sings the line, “Lug our sorrows, pains and angers and turn them into play,” it’s a reminder that even with some age on the wheels, his band is still finding creative ways to roll with the punches.
continue reading » Building a business intelligence (BI) program starts with one question: Why?“Too many people are affected by ‘shiny object syndrome,’” where they’re distracted by the latest new tool, says Anne Legg, director of market/client strategy for AdvantEdge Analytics, a CUNA Strategic Services alliance provider. “Start by asking, ‘what is your why?’ What do you want to accomplish with business intelligence?”Legg, who addressed the 2019 CUNA Finance Council Conference Sunday in New York City, defines BI as the process of leveraging technology to analyze data with the intent to deliver actionable information that’s easy to digest.“The primary goal of BI is to enable and empower all levels of credit union leadership to make data-driven decisions that are in the best interest of members, the credit union, and the community,” she says. “You have a lot of data and a lot of ways to leverage it.” ShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr
Press Association The Spaniard has been in talks with the club over the last couple of days after the Toffees agreed a compensation deal, believed to be about £1.5million, with Wigan. Martinez, 39, has always been the long-time favourite to succeed Manchester United-bound David Moyes after his 11 years in charge. Everton have called a press conference on Wednesday afternoon at which it is expected Roberto Martinez will be unveiled as their new manager. Martinez emerged as the outright first choice of chairman Bill Kenwright after he considered a three-man shortlist, believed to also include Porto’s Vitor Pereira and former Schalke coach Ralf Rangnick, over the weekend. However, the Toffees’ interest in the Latics boss was registered some time before that when it became clear the Spaniard was considering his position following their relegation from the Premier League. Everton made an official approach on May 24 and four days later Martinez told Wigan chairman Dave Whelan he wanted to leave as he did not feel up to the task of getting the club out of the npower Championship. However, despite the negative connotations of taking a team down Martinez enhanced his reputation by winning the FA Cup – something Moyes never achieved – by beating Manchester City at Wembley last month. He is renowned for playing an attractive style of football and working on a relatively stringent budget, both of which appealed to the Goodison hierarchy. Former Everton striker Kevin Campbell believes Martinez will be “a breath of fresh air” after Moyes’ more regimented approach. “The way he plays the game, the fans are going to like the style, and I think the players are going to improve, and that’s really important,” he said. “Everton have wonderfully gifted players and I think he will give them a new lease of life.”
The Irish fighter – arguably the greatest female boxer of her time – saw off Estelle Mosseley to lift the 60kg crowd in Bucharest. Taylor, 28, won on the scorecard of all three judges. Press Association Katie Taylor recorded a sixth successive European title win on Saturday. The victory is her 16th major title, which includes Olympic gold, four world titles and six European Union titles. “Thanks everyone for all your support and prayers,” she wrote on Twitter. “Six X European Champion!! To God be the glory….always!!!” There was no gold medal joy for English duo Natasha Jonas and Stacey Copeland, though. Jonas was beaten 3-0 by Anastasia Beliakova in the 64kg category, while Copeland was seen off by Elena Vystropova by the same scoreline in the 69kg section. “Though not at my preferred weight today I got a European silver,” Jonas tweeted. “I had a job to do, a point to prove.”
Published on February 13, 2015 at 12:49 am Facebook Twitter Google+ Editor’s note: Two beat writers were assigned to make a case for which player they would rather have for one game — one for Syracuse’s Rakeem Christmas, one for Duke’s Jahlil Okafor.Don’t get me wrong — Rakeem Christmas is having a hell of a season.He’s enjoyed a relatively unprecedented spike in production for a Syracuse big man. A year after being the Orange’s fourth scoring option — and I use the word option cautiously — he’s in the conversation with the country’s best post players.I’d gladly have his production on my team. But I wouldn’t pass on Jahlil Okafor first.The 6-foot-11, 270-pound Duke freshman is in line for a ton of accolades this season and will probably be the first player to emerge from the green room at the NBA Draft. Christmas’ draft potential won’t even land him in the arena that day. In the long term, this isn’t much of a debate. On a one-day rental, though, it’s closer — but I’m still taking Okafor.AdvertisementThis is placeholder textHe’ll likely have his way against Christmas and the Orange on Saturday — partly because SU doesn’t have the depth to play Duke physically, but also partly because he’s just a more talented big man than Christmas is.“He has a toughness. Jah’s special in every way,” Duke head coach Mike Krzyzewski told reporters after Duke beat Boston College on Jan. 3. “He’s really got everything.”Maybe not everything — Okafor’s defense is suspect, particularly in the pick-and-roll game.But on the other hand, we haven’t seen Christmas defend anybody man-to-man for a whole game since high school. And in my hypothetical one-game moonlight as a head coach, zone probably wouldn’t be the way to go.Even though Christmas moves quickly enough to be a better one-on-one defender than Okafor, what the Duke center brings to the table offensively more than makes up for his defensive inabilities.Not only does he have 2 inches and 20 pounds on Christmas, but Okafor — who grabs more offensive rebounds than any other Atlantic Coast Conference player — uses his size better than the SU senior does. Christmas is an imposing big man, but a bit too thin to body up some of the country’s biggest post players — not that SU’s thin rotation would allow him to do that anyway.Don’t be swayed by the fact Christmas has exploded for 35 points this season and slightly edges Okafor in the rebounding column. The SU big man has played five consecutive full games. Okafor has spent more than 35 minutes on the floor in just two games this season — and has still scored in double digits in every game, unlike Christmas.But numbers aside, let’s get down to the skill sets.Christmas has really come a long way offensively. His footwork, baby hook and shooting touch from point-blank range are miles better from when he came to SU as a defensive and rebounding specialist. And he’s made good decisions when ACC teams have sent double teams his way.But Okafor takes it a step further. His inventiveness around the basket — switching hands seamlessly at the rim, reversing direction from seemingly dead spots in the paint and, most of all, converting from anywhere — is something no other big man in the country can compete with.“I was just trying to be aggressive and send a message that one man can’t guard me,” Okafor told reporters after Duke routed Notre Dame last Saturday.With his massive hands, hauling in entry passes and kicking them back out of double teams is nearly effortless — and Okafor’s been doing that since before ACC play began.Christmas can only receive the ball in so many spots on the court and be effective. Okafor makes it work with whatever space he’s given. Surround him with shooters, like Krzyzewski has, and Okafor’s even more of a weapon.Christmas doesn’t dribble well enough to get to spots like Okafor does, and he doesn’t connect from midrange nearly well enough, either — the two biggest clouds hanging over the SU big man’s NBA prospects, aside from his size.But again, this debate isn’t about the big picture.It’s about the one who can simply do more with the ball in his hands.Phil D’Abbraccio is the sports editor at The Daily Orange, where his column appears occasionally. He can be reached at [email protected] or on Twitter at @PhilDAbb. Comments
Roger Federer has not won a Grand Slam title this year but the 17-time Grand Slam champion topped Forbes magazine’s list of the 10 top tennis moneymakers announced Monday.The Swiss star made $56.2 million (42.6 million euros) from July of last year through this past June, with endorsement deals from such firms as Rolex and Nike bringing the lion’s share of that total, more than $40 million (30 million euros).At age 33, Federer owns three titles in 2014 and was a Wimbledon runner-up, dropping the final in five sets to top-ranked Novak Djokovic.Five men and five women made this year’s list.Spaniard Rafael Nadal, who won his ninth French Open crown this past June, ranked second on the list at $44.5 million (33.7 million euros) but was on the sidelines on Monday as the US Open began in New York because of a wrist injury. Nadal had $30 million (22.7 million euros) in sponsor money.Serbia’s Djokovic was third with $33.1 million (25 million euros) that included $12.1 million (9.1 million euros) in prize money. Russian beauty Maria Sharapova was fourth overall but topped the women on the list with $24.4 million (18.5 million euros), $22 million (16.6 million euros) of it from endorsements.China’s Li Na, who won her second Grand Slam title in January at the Australian Open, was fifth on $23.6 million with $18 million in endorsement income. She is absent from the US Open with a knee injury.World number one Serena Williams ranked sixth on the money list with $22 million, half from prize money.Britain’s Andy Murray, whose earnings jumped more than $4 million after he became the first British man to win the Wimbledon crown since 1936 last year, ranked seventh on $19.1 million (14.4 million in euros), with $15 million (11.3 million euros) of that from endorsements.With his adidas contract expiring this year, a lucrative new deal with adidas or Nike could raise his total next year no matter how he fares at this year’s US Open. Victoria Azarenka was eighth at $11.1 million (8.4 million euros), with $7.5 million (5.6 million euros) from endorsements, with Japan’s Kei Nishikori ninth on $11 million 8.3 million euros) that included $9 million (6.8 million euros) in sponsorship deals and Denmark’s Caroline Wozniacki 10th on $10.8 million (8.1 million euros), $9.5 million (7.2 million euros)of that from endorsements.